Company profile: Glytec
1.1 - Company Overview
Company description
- Provider of insulin management software, including Glucommander for algorithm-based dosing in inpatient and outpatient care and eGlycemic Management System (eGMS), a cloud-based, EHR-integrated platform for glycemic management, continuous blood glucose monitoring, and analytics. Includes GlucoSurveillance, GlucoView, GlucoMetrics, and quality initiatives for education, support, and performance monitoring.
Products and services
- EGlycemic Management System (eGMS): A cloud-based platform that delivers glycemic management and insulin dosing, offering tools for continuous blood glucose monitoring and analytics to guide care decisions
- Glucommander: An algorithm-driven insulin dosing application that engineers personalized insulin therapy recommendations for both inpatient and outpatient care
- GlucoMetrics: An analytics-driven reporting module within eGMS that produces dashboards and data to optimize glycemic management and support continuous improvement
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Glytec
Kode Health
HQ: United States
Website
- Description: Provider of an on-demand medical coding platform connecting healthcare providers with vetted, certified coders in real time for flexible, project-based work, offering KODE Connect for staffing without long-term commitments and KODE Flex integrating with existing EMR systems to deliver flexibility, quality, and control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kode Health company profile →
Keya Medical
HQ: China
Website
- Description: Provider of AI-driven cardiovascular and neurological solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Keya Medical company profile →
Redox
HQ: United States
Website
- Description: Provider of an EHR integration and healthcare platform that accelerates the development and distribution of healthcare software solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Redox company profile →
Cogstate
HQ: United States
Website
- Description: Provider of rapid, computerized cognitive assessment and training solutions, including a global Clinical and Scientific Network that supports biopharmaceutical research with quality assessments of cognition, mood, behavior, neurodevelopment, and motor function, and Cognigram, a web-based platform delivering brain health assessments for clinical trials and healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cogstate company profile →
CodaMetrix
HQ: United States
Website
- Description: Provider of an AI-powered autonomous medical coding platform for healthcare revenue cycle management, translating clinical notes into billing and diagnostic codes without human intervention. Offers a cloud-based solution for patient care and revenue cycle management and CMX Amplify, a coding decision support tool embedded in EHR systems to assist coders with complex cases, improving efficiency and accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CodaMetrix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Glytec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Glytec
2.2 - Growth funds investing in similar companies to Glytec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Glytec
4.2 - Public trading comparable groups for Glytec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →